December 4, 2020 by Chain Drug Review
bamlanivimab (LY-CoV555) in high-risk, COVID-19, COVID-19 infected individuals, Eli Lilly and Co., UnitedHealth Group
Leading Headlines, Pharmacy

INDIANAPOLIS — Eli Lilly and Co. and the UnitedHealth Group have announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals. Bamlanivimab recently received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration for the treatment of mild to moderate COVID-19 patients who are at high risk
October 1, 2018 by Chain Drug Review
Genoa Healthcare, OptumRx, UnitedHealth Group
Featured Articles, Leading Headlines, Pharmacy

MINNETONKA, Minn. — UnitedHealth Group has confirmed that its OptumRx division for pharmacy services is combining operations with Genoa Healthcare, which runs 435 pharmacies in behavioral health centers in 46 states. An unnamed source familiar with the deal, reported that UnitedHealth, which is based here, paid about $2.5 billion to acquire Genoa. OptumRx spokesperson Drew
April 17, 2018 by Chain Drug Review
GSK, Optum, UnitedHealth Group
Issue 04-09-2018, News
MINNEAPOLIS — UnitedHealth Group has tapped former GlaxoSmithKline PLC (GSK) chief executive officer Sir Andrew Witty as the next CEO of Optum, its health services, technology and pharmacy benefits management unit. The appointment is effective July 1. Witty, 53, will succeed Larry Renfro, who is set to lead UnitedHealth Group’s enterprise growth efforts and Optum’s
March 13, 2018 by Chain Drug Review
Andrew Witty, David Wichmann, GlaxoSmithKline, Larry Renfro, Optum, OptumRx, UnitedHealth Group
Business, Leading Headlines, Pharmacy, Supplier News

MINNEAPOLIS — Former GlaxoSmithKline plc chief executive officer Sir Andrew Witty has been named CEO of Optum, the health services, technology and pharmacy benefits management unit of health insurance giant UnitedHealth Group. Plans call for Witty to start as Optum CEO on July 1. He takes over from Larry Renfro, vice chair of UnitedHealth Group, who has
March 13, 2018 by Chain Drug Review
Aetna, Amazon, Berskhire Hathaway, Cigna, CVS Health, CVS-Aetna merger, Express Scripts, JPMorgan Chase, Larry Merlo, Mark Bertolini, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I. — Shareholders of CVS Health voted overwhelmingly to approve the company’s $69 billion deal to acquire health insurer Aetna Inc. CVS said that in a special stockholders meeting on Tuesday, more than 98% of shares were voted in favor of the CVS-Aetna merger agreement, which was announced in early December. Also at a
February 26, 2018 by Greg Jacobson and Chain Drug Review
Aetna, Albertsons, Amazon, AmerisourceBergen, Berkshire Hathaway, CVS Health, Health Transformation Alliance, John Standley, JPMorgan Chase, Rite Aid, Stefano Pessina, U.S. health care industry, U.S. health care sector, UnitedHealth Group, Walgreens Boots Alliance
2018, Featured Articles, Issue 02-26-2018, Issues, Leading Headlines, News, Pharmacy, Retail News

NEW YORK — The U.S. health care industry has been in flux for a number of years, but the pace of transformation now appears to be accelerating rapidly. Several of the biggest players in the U.S. health care sector are making moves to confront an uncertain future — one that may bring unwelcome competition and
November 20, 2017 by Chain Drug Review
Aetna, Amazon, CVS Health, CVS-Aetna merger, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Retail News

NEW YORK — A deal for CVS Health to acquire Aetna Inc. could happen by the end of the month, published reports say. Citing anonymous sources, The Wall Street Journal reported Monday that CVS was nearing a $66 billion agreement to buy the health insurer, according to reports. The news of a potential CVS-Aetna merger
December 12, 2016 by Geoff Walden and Chain Drug Review
CVS Pharmacy, Helena Foulkes, Mark Thierer, OptumRx, UnitedHealth Group
2016, Issue 12-12-2016, Issues, News
WOONSOCKET, R.I. — CVS Pharmacy is partnering with OptumRx, the PBM subsidiary of UnitedHealth Group, to boost convenience and lower costs for consumers and clients while improving outcomes. The two companies will offer employers a new pharmacy network program providing eligible OptumRx members the option to fill 90-day prescriptions at prices equal to home delivery
November 29, 2016 by Chain Drug Review
CVS Pharmacy, Helena Foulkes, Mark Thierer, OptumRx, UnitedHealth Group
Featured Articles, Leading Headlines, Pharmacy, Retail News

WOONSOCKET, R.I., and CHICAGO — UnitedHealth Group’s OptumRx aims to bring more prescription drug and pharmacy care options to clients and members through a new partnership with CVS Pharmacy. The companies said Tuesday that they will offer employers a new pharmacy network solution enabling eligible OptumRx members to fill 90-day prescriptions at the more than
September 6, 2016 by Geoff Walden and Chain Drug Review
ACA enrollment, Aetna, Affordable Care Act, Drew Altman, health insurance exchanges, health insurance marketplaces, Humana, Kaiser Family Foundation, Marilyn Tavenner, Mark Bertolini, UnitedHealth Group
Issue 09-12-2016, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — The pullback of health insurance companies from the Affordable Care Act has focused a harsh light on President Obama’s signature legislative achievement. Most recently, Aetna Inc. decided to drop out of ACA health insurance exchanges in 11 states with about two-thirds of the 778 counties where it now offers coverage. It will continue
December 7, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, health insurance exchanges, Health Insurance Marketplace, HealthCare.gov, UnitedHealth Group
2015, Issue 12-07-2015, Issues, Leading Headlines, News, Pharmacy, Retail News

NEW YORK — UnitedHealth Group Inc. may pull out of Affordable Care Act health insurance exchanges in 2017 after losing what it said were hundreds of millions of dollars on policies sold under the law. The company, the nation’s largest health insurer, significantly cut its 2015 profit estimates based on losses on individual policies sold
March 30, 2015 by Chain Drug Review and Chain Drug Review
Catamaran Corp., Larry Renfro, Mark Thierer, Optum, OptumRx, PBM, pharmacy benefit management, Timothy Wicks, UnitedHealth Group
Business, Leading Headlines, Pharmacy, Retail News

NEW YORK and SCHAUMBURG, Ill. — Reflecting the ongoing consolidation in the pharmacy benefit management (PBM) sector, UnitedHealth Group plans to acquire Catamaran Corp. in a deal valued at $12.8 billion. The companies said Monday that Catamaran would integrated into OptumRx, UnitedHealth’s freestanding pharmacy care services business and part of its Optum health services unit.